A diabetes network for pharmacists How pharmacy services are catching on with private payersA small but growing number of private payers in the rest of the country are looking at how pharmacists’ expanded scope of practice and the growing range of services could help manage rising drug costs and improve health outcomes for staff. Trulicity and Bydureon: two new injectables for type 2 diabetes First once-weekly glucagon-like peptide-1 receptor agonists reach the Canadian market. Basaglar: first subsequent entry biologic for insulin glargine Approved for use in adults and children older than six years. Johnson & Johnson, ViaCyte testing possible diabetes cure Companies co-developing first stem cell treatment for the disease. EXCLUSIVE VIDEO: Insulin for type 2 diabetes Diabetes: We need to do better, says CIHI report Canada has one of the highest prevalence rates among developed countries Type 2 diabetes: The new drugs in town What you need to know about sodium- glucose linked transporter 2 inhibitors Humalog KwikPen 200 units/mL: new higher-strength pen now available More concentrated product for patients who need more than 20 units of rapid-acting insulin per day. Tools for your diabetes patients that will help you in your practice A guide to the Canadian Diabetes Association's online resources First Previous 34 35 36 37 38 Next Last
